United States Tumor Necrosis Factor Inhibitor Market Report 2016

November 2016 | 101 pages | ID: UA91131B47CEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Tumor Necrosis Factor Inhibitor

Revenue, means the sales value of Tumor Necrosis Factor Inhibitor

This report studies sales (consumption) of Tumor Necrosis Factor Inhibitor in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Dexa Medica
• GlaxoSmithKline
• Sanofi
• MedImmune
• Reliance Life Sciences
• Novartis
• Delenex Therapeutics
• Janssen Biotech
• Toyama Chemical
• Zydus Cadila

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Tumor Necrosis Factor Inhibitor in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Tumor Necrosis Factor Inhibitor Market Report 2016

1 TUMOR NECROSIS FACTOR INHIBITOR OVERVIEW

1.1 Product Overview and Scope of Tumor Necrosis Factor Inhibitor
1.2 Classification of Tumor Necrosis Factor Inhibitor
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Tumor Necrosis Factor Inhibitor
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Tumor Necrosis Factor Inhibitor (2011-2021)
  1.4.1 United States Tumor Necrosis Factor Inhibitor Sales and Growth Rate (2011-2021)
  1.4.2 United States Tumor Necrosis Factor Inhibitor Revenue and Growth Rate (2011-2021)

2 UNITED STATES TUMOR NECROSIS FACTOR INHIBITOR COMPETITION BY MANUFACTURERS

2.1 United States Tumor Necrosis Factor Inhibitor Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Tumor Necrosis Factor Inhibitor Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Tumor Necrosis Factor Inhibitor Average Price by Manufactures (2015 and 2016)
2.4 Tumor Necrosis Factor Inhibitor Market Competitive Situation and Trends
  2.4.1 Tumor Necrosis Factor Inhibitor Market Concentration Rate
  2.4.2 Tumor Necrosis Factor Inhibitor Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES TUMOR NECROSIS FACTOR INHIBITOR SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Tumor Necrosis Factor Inhibitor Sales and Market Share by Type (2011-2016)
3.2 United States Tumor Necrosis Factor Inhibitor Revenue and Market Share by Type (2011-2016)
3.3 United States Tumor Necrosis Factor Inhibitor Price by Type (2011-2016)
3.4 United States Tumor Necrosis Factor Inhibitor Sales Growth Rate by Type (2011-2016)

4 UNITED STATES TUMOR NECROSIS FACTOR INHIBITOR SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Tumor Necrosis Factor Inhibitor Sales and Market Share by Application (2011-2016)
4.2 United States Tumor Necrosis Factor Inhibitor Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES TUMOR NECROSIS FACTOR INHIBITOR MANUFACTURERS PROFILES/ANALYSIS

5.1 Dexa Medica
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Tumor Necrosis Factor Inhibitor Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Dexa Medica Tumor Necrosis Factor Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 GlaxoSmithKline
  5.2.2 Tumor Necrosis Factor Inhibitor Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 GlaxoSmithKline Tumor Necrosis Factor Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Sanofi
  5.3.2 Tumor Necrosis Factor Inhibitor Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Sanofi Tumor Necrosis Factor Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 MedImmune
  5.4.2 Tumor Necrosis Factor Inhibitor Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 MedImmune Tumor Necrosis Factor Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Reliance Life Sciences
  5.5.2 Tumor Necrosis Factor Inhibitor Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Reliance Life Sciences Tumor Necrosis Factor Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Novartis
  5.6.2 Tumor Necrosis Factor Inhibitor Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Novartis Tumor Necrosis Factor Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Delenex Therapeutics
  5.7.2 Tumor Necrosis Factor Inhibitor Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Delenex Therapeutics Tumor Necrosis Factor Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Janssen Biotech
  5.8.2 Tumor Necrosis Factor Inhibitor Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Janssen Biotech Tumor Necrosis Factor Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Toyama Chemical
  5.9.2 Tumor Necrosis Factor Inhibitor Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Toyama Chemical Tumor Necrosis Factor Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Zydus Cadila
  5.10.2 Tumor Necrosis Factor Inhibitor Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Zydus Cadila Tumor Necrosis Factor Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview

6 TUMOR NECROSIS FACTOR INHIBITOR MANUFACTURING COST ANALYSIS

6.1 Tumor Necrosis Factor Inhibitor Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Tumor Necrosis Factor Inhibitor

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Tumor Necrosis Factor Inhibitor Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Tumor Necrosis Factor Inhibitor Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES TUMOR NECROSIS FACTOR INHIBITOR MARKET FORECAST (2016-2021)

10.1 United States Tumor Necrosis Factor Inhibitor Sales, Revenue Forecast (2016-2021)
10.2 United States Tumor Necrosis Factor Inhibitor Sales Forecast by Type (2016-2021)
10.3 United States Tumor Necrosis Factor Inhibitor Sales Forecast by Application (2016-2021)
10.4 Tumor Necrosis Factor Inhibitor Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Tumor Necrosis Factor Inhibitor
Table Classification of Tumor Necrosis Factor Inhibitor
Figure United States Sales Market Share of Tumor Necrosis Factor Inhibitor by Type in 2015
Table Application of Tumor Necrosis Factor Inhibitor
Figure United States Sales Market Share of Tumor Necrosis Factor Inhibitor by Application in 2015
Figure United States Tumor Necrosis Factor Inhibitor Sales and Growth Rate (2011-2021)
Figure United States Tumor Necrosis Factor Inhibitor Revenue and Growth Rate (2011-2021)
Table United States Tumor Necrosis Factor Inhibitor Sales of Key Manufacturers (2015 and 2016)
Table United States Tumor Necrosis Factor Inhibitor Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Tumor Necrosis Factor Inhibitor Sales Share by Manufacturers
Figure 2016 Tumor Necrosis Factor Inhibitor Sales Share by Manufacturers
Table United States Tumor Necrosis Factor Inhibitor Revenue by Manufacturers (2015 and 2016)
Table United States Tumor Necrosis Factor Inhibitor Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Tumor Necrosis Factor Inhibitor Revenue Share by Manufacturers
Table 2016 United States Tumor Necrosis Factor Inhibitor Revenue Share by Manufacturers
Table United States Market Tumor Necrosis Factor Inhibitor Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Tumor Necrosis Factor Inhibitor Average Price of Key Manufacturers in 2015
Figure Tumor Necrosis Factor Inhibitor Market Share of Top 3 Manufacturers
Figure Tumor Necrosis Factor Inhibitor Market Share of Top 5 Manufacturers
Table United States Tumor Necrosis Factor Inhibitor Sales by Type (2011-2016)
Table United States Tumor Necrosis Factor Inhibitor Sales Share by Type (2011-2016)
Figure United States Tumor Necrosis Factor Inhibitor Sales Market Share by Type in 2015
Table United States Tumor Necrosis Factor Inhibitor Revenue and Market Share by Type (2011-2016)
Table United States Tumor Necrosis Factor Inhibitor Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Tumor Necrosis Factor Inhibitor by Type (2011-2016)
Table United States Tumor Necrosis Factor Inhibitor Price by Type (2011-2016)
Figure United States Tumor Necrosis Factor Inhibitor Sales Growth Rate by Type (2011-2016)
Table United States Tumor Necrosis Factor Inhibitor Sales by Application (2011-2016)
Table United States Tumor Necrosis Factor Inhibitor Sales Market Share by Application (2011-2016)
Figure United States Tumor Necrosis Factor Inhibitor Sales Market Share by Application in 2015
Table United States Tumor Necrosis Factor Inhibitor Sales Growth Rate by Application (2011-2016)
Figure United States Tumor Necrosis Factor Inhibitor Sales Growth Rate by Application (2011-2016)
Table Dexa Medica Basic Information List
Table Dexa Medica Tumor Necrosis Factor Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Dexa Medica Tumor Necrosis Factor Inhibitor Sales Market Share (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Tumor Necrosis Factor Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Tumor Necrosis Factor Inhibitor Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Tumor Necrosis Factor Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Tumor Necrosis Factor Inhibitor Sales Market Share (2011-2016)
Table MedImmune Basic Information List
Table MedImmune Tumor Necrosis Factor Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table MedImmune Tumor Necrosis Factor Inhibitor Sales Market Share (2011-2016)
Table Reliance Life Sciences Basic Information List
Table Reliance Life Sciences Tumor Necrosis Factor Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Reliance Life Sciences Tumor Necrosis Factor Inhibitor Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Tumor Necrosis Factor Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Tumor Necrosis Factor Inhibitor Sales Market Share (2011-2016)
Table Delenex Therapeutics Basic Information List
Table Delenex Therapeutics Tumor Necrosis Factor Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Delenex Therapeutics Tumor Necrosis Factor Inhibitor Sales Market Share (2011-2016)
Table Janssen Biotech Basic Information List
Table Janssen Biotech Tumor Necrosis Factor Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Janssen Biotech Tumor Necrosis Factor Inhibitor Sales Market Share (2011-2016)
Table Toyama Chemical Basic Information List
Table Toyama Chemical Tumor Necrosis Factor Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Toyama Chemical Tumor Necrosis Factor Inhibitor Sales Market Share (2011-2016)
Table Zydus Cadila Basic Information List
Table Zydus Cadila Tumor Necrosis Factor Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Zydus Cadila Tumor Necrosis Factor Inhibitor Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Tumor Necrosis Factor Inhibitor
Figure Manufacturing Process Analysis of Tumor Necrosis Factor Inhibitor
Figure Tumor Necrosis Factor Inhibitor Industrial Chain Analysis
Table Raw Materials Sources of Tumor Necrosis Factor Inhibitor Major Manufacturers in 2015
Table Major Buyers of Tumor Necrosis Factor Inhibitor
Table Distributors/Traders List
Figure United States Tumor Necrosis Factor Inhibitor Production and Growth Rate Forecast (2016-2021)
Figure United States Tumor Necrosis Factor Inhibitor Revenue and Growth Rate Forecast (2016-2021)
Table United States Tumor Necrosis Factor Inhibitor Production Forecast by Type (2016-2021)
Table United States Tumor Necrosis Factor Inhibitor Consumption Forecast by Application (2016-2021)